Global Artificial Implants Market Research Report 2021

1 Artificial Implants Market Overview

• 1.1 Product Overview and Scope of Artificial Implants
• 1.2 Artificial Implants Segment by Type
  • 1.2.1 Global Artificial Implants Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Orthopedic Implants
  • 1.2.3 Dental Implants
  • 1.2.4 Cardiac Implants
  • 1.2.5 Cochlear Implants
• 1.3 Artificial Implants Segment by Application
  • 1.3.1 Artificial Implants Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospitals
  • 1.3.3 Clinical Research Institutions
  • 1.3.4 Others
• 1.4 Global Artificial Implants Market Size Estimates and Forecasts
  • 1.4.1 Global Artificial Implants Revenue 2016-2027
  • 1.4.2 Global Artificial Implants Sales 2016-2027
  • 1.4.3 Artificial Implants Market Size by Region: 2016 Versus 2021 Versus 2027

2 Artificial Implants Market Competition by Manufacturers

• 2.1 Global Artificial Implants Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Artificial Implants Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Artificial Implants Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Artificial Implants Manufacturing Sites, Area Served, Product Type
• 2.5 Artificial Implants Market Competitive Situation and Trends
  • 2.5.1 Artificial Implants Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Artificial Implants Players Market Share by Revenue
  • 2.5.3 Global Artificial Implants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Artificial Implants Retrospective Market Scenario by Region

• 3.1 Global Artificial Implants Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Artificial Implants Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Artificial Implants Market Facts & Figures by Country
  • 3.3.1 North America Artificial Implants Sales by Country
  • 3.3.2 North America Artificial Implants Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Artificial Implants Market Facts & Figures by Country
  • 3.4.1 Europe Artificial Implants Sales by Country
  • 3.4.2 Europe Artificial Implants Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Artificial Implants Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Artificial Implants Sales by Region
  • 3.5.2 Asia Pacific Artificial Implants Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Artificial Implants Market Facts & Figures by Country
  • 3.6.1 Latin America Artificial Implants Sales by Country
  • 3.6.2 Latin America Artificial Implants Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Artificial Implants Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Artificial Implants Sales by Country
  • 3.7.2 Middle East and Africa Artificial Implants Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Artificial Implants Historic Market Analysis by Type

• 4.1 Global Artificial Implants Sales Market Share by Type (2016-2021)
• 4.2 Global Artificial Implants Revenue Market Share by Type (2016-2021)
• 4.3 Global Artificial Implants Price by Type (2016-2021)

5 Global Artificial Implants Historic Market Analysis by Application

• 5.1 Global Artificial Implants Sales Market Share by Application (2016-2021)
• 5.2 Global Artificial Implants Revenue Market Share by Application (2016-2021)
• 5.3 Global Artificial Implants Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Abiomed (USA)
  • 6.1.1 Abiomed (USA) Corporation Information
  • 6.1.2 Abiomed (USA) Description and Business Overview
  • 6.1.3 Abiomed (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Abiomed (USA) Product Portfolio
  • 6.1.5 Abiomed (USA) Recent Developments/Updates
• 6.2 Advanced Bionics Corporation (USA)
  • 6.2.1 Advanced Bionics Corporation (USA) Corporation Information
  • 6.2.2 Advanced Bionics Corporation (USA) Description and Business Overview
  • 6.2.3 Advanced Bionics Corporation (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Advanced Bionics Corporation (USA) Product Portfolio
  • 6.2.5 Advanced Bionics Corporation (USA) Recent Developments/Updates
• 6.3 Bicon(USA)
  • 6.3.1 Bicon(USA) Corporation Information
  • 6.3.2 Bicon(USA) Description and Business Overview
  • 6.3.3 Bicon(USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Bicon(USA) Product Portfolio
  • 6.3.5 Bicon(USA) Recent Developments/Updates
• 6.4 Biomet 3i (USA)
  • 6.4.1 Biomet 3i (USA) Corporation Information
  • 6.4.2 Biomet 3i (USA) Description and Business Overview
  • 6.4.3 Biomet 3i (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Biomet 3i (USA) Product Portfolio
  • 6.4.5 Biomet 3i (USA) Recent Developments/Updates
• 6.5 Biotronik(Germany)
  • 6.5.1 Biotronik(Germany) Corporation Information
  • 6.5.2 Biotronik(Germany) Description and Business Overview
  • 6.5.3 Biotronik(Germany) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Biotronik(Germany) Product Portfolio
  • 6.5.5 Biotronik(Germany) Recent Developments/Updates
• 6.6 Boston Scientific Corporation (USA)
  • 6.6.1 Boston Scientific Corporation (USA) Corporation Information
  • 6.6.2 Boston Scientific Corporation (USA) Description and Business Overview
  • 6.6.3 Boston Scientific Corporation (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Boston Scientific Corporation (USA) Product Portfolio
  • 6.6.5 Boston Scientific Corporation (USA) Recent Developments/Updates
• 6.7 Cochlear Limited (Australia)
  • 6.6.1 Cochlear Limited (Australia) Corporation Information
  • 6.6.2 Cochlear Limited (Australia) Description and Business Overview
  • 6.6.3 Cochlear Limited (Australia) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Cochlear Limited (Australia) Product Portfolio
  • 6.7.5 Cochlear Limited (Australia) Recent Developments/Updates
• 6.8 Dentsply Sirona (USA)
  • 6.8.1 Dentsply Sirona (USA) Corporation Information
  • 6.8.2 Dentsply Sirona (USA) Description and Business Overview
  • 6.8.3 Dentsply Sirona (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Dentsply Sirona (USA) Product Portfolio
  • 6.8.5 Dentsply Sirona (USA) Recent Developments/Updates
• 6.9 DePuy Synthes Companies (USA)
  • 6.9.1 DePuy Synthes Companies (USA) Corporation Information
  • 6.9.2 DePuy Synthes Companies (USA) Description and Business Overview
  • 6.9.3 DePuy Synthes Companies (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 DePuy Synthes Companies (USA) Product Portfolio
  • 6.9.5 DePuy Synthes Companies (USA) Recent Developments/Updates
• 6.10 Exactech (USA)
  • 6.10.1 Exactech (USA) Corporation Information
  • 6.10.2 Exactech (USA) Description and Business Overview
  • 6.10.3 Exactech (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Exactech (USA) Product Portfolio
  • 6.10.5 Exactech (USA) Recent Developments/Updates
• 6.11 GS Medical(USA)
  • 6.11.1 GS Medical(USA) Corporation Information
  • 6.11.2 GS Medical(USA) Artificial Implants Description and Business Overview
  • 6.11.3 GS Medical(USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 GS Medical(USA) Product Portfolio
  • 6.11.5 GS Medical(USA) Recent Developments/Updates
• 6.12 Institut Straumann AG (Switzerland)
  • 6.12.1 Institut Straumann AG (Switzerland) Corporation Information
  • 6.12.2 Institut Straumann AG (Switzerland) Artificial Implants Description and Business Overview
  • 6.12.3 Institut Straumann AG (Switzerland) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Institut Straumann AG (Switzerland) Product Portfolio
  • 6.12.5 Institut Straumann AG (Switzerland) Recent Developments/Updates
• 6.13 Integra Lifesciences Holdings Corporation (USA)
  • 6.13.1 Integra Lifesciences Holdings Corporation (USA) Corporation Information
  • 6.13.2 Integra Lifesciences Holdings Corporation (USA) Artificial Implants Description and Business Overview
  • 6.13.3 Integra Lifesciences Holdings Corporation (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Integra Lifesciences Holdings Corporation (USA) Product Portfolio
  • 6.13.5 Integra Lifesciences Holdings Corporation (USA) Recent Developments/Updates
• 6.14 Japan Medical Dynamic Marketing (Japan)
  • 6.14.1 Japan Medical Dynamic Marketing (Japan) Corporation Information
  • 6.14.2 Japan Medical Dynamic Marketing (Japan) Artificial Implants Description and Business Overview
  • 6.14.3 Japan Medical Dynamic Marketing (Japan) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Japan Medical Dynamic Marketing (Japan) Product Portfolio
  • 6.14.5 Japan Medical Dynamic Marketing (Japan) Recent Developments/Updates
• 6.15 MED-EL Medical Electronics (Austria)
  • 6.15.1 MED-EL Medical Electronics (Austria) Corporation Information
  • 6.15.2 MED-EL Medical Electronics (Austria) Artificial Implants Description and Business Overview
  • 6.15.3 MED-EL Medical Electronics (Austria) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 MED-EL Medical Electronics (Austria) Product Portfolio
  • 6.15.5 MED-EL Medical Electronics (Austria) Recent Developments/Updates
• 6.16 Medtronic plc (Ireland)
  • 6.16.1 Medtronic plc (Ireland) Corporation Information
  • 6.16.2 Medtronic plc (Ireland) Artificial Implants Description and Business Overview
  • 6.16.3 Medtronic plc (Ireland) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Medtronic plc (Ireland) Product Portfolio
  • 6.16.5 Medtronic plc (Ireland) Recent Developments/Updates
• 6.17 Nobel Biocare Services AG (Sweden)
  • 6.17.1 Nobel Biocare Services AG (Sweden) Corporation Information
  • 6.17.2 Nobel Biocare Services AG (Sweden) Artificial Implants Description and Business Overview
  • 6.17.3 Nobel Biocare Services AG (Sweden) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Nobel Biocare Services AG (Sweden) Product Portfolio
  • 6.17.5 Nobel Biocare Services AG (Sweden) Recent Developments/Updates
• 6.18 RTI Surgical (USA)
  • 6.18.1 RTI Surgical (USA) Corporation Information
  • 6.18.2 RTI Surgical (USA) Artificial Implants Description and Business Overview
  • 6.18.3 RTI Surgical (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 RTI Surgical (USA) Product Portfolio
  • 6.18.5 RTI Surgical (USA) Recent Developments/Updates
• 6.19 Showa Ika Kohgyo (Japan)
  • 6.19.1 Showa Ika Kohgyo (Japan) Corporation Information
  • 6.19.2 Showa Ika Kohgyo (Japan) Artificial Implants Description and Business Overview
  • 6.19.3 Showa Ika Kohgyo (Japan) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Showa Ika Kohgyo (Japan) Product Portfolio
  • 6.19.5 Showa Ika Kohgyo (Japan) Recent Developments/Updates
• 6.20 Smith & Nephew Plc (UK)
  • 6.20.1 Smith & Nephew Plc (UK) Corporation Information
  • 6.20.2 Smith & Nephew Plc (UK) Artificial Implants Description and Business Overview
  • 6.20.3 Smith & Nephew Plc (UK) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.20.4 Smith & Nephew Plc (UK) Product Portfolio
  • 6.20.5 Smith & Nephew Plc (UK) Recent Developments/Updates
• 6.21 Sonova Holding AG (Switzerland)
  • 6.21.1 Sonova Holding AG (Switzerland) Corporation Information
  • 6.21.2 Sonova Holding AG (Switzerland) Artificial Implants Description and Business Overview
  • 6.21.3 Sonova Holding AG (Switzerland) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.21.4 Sonova Holding AG (Switzerland) Product Portfolio
  • 6.21.5 Sonova Holding AG (Switzerland) Recent Developments/Updates
• 6.22 Abbott
  • 6.22.1 Abbott Corporation Information
  • 6.22.2 Abbott Artificial Implants Description and Business Overview
  • 6.22.3 Abbott Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.22.4 Abbott Product Portfolio
  • 6.22.5 Abbott Recent Developments/Updates
• 6.23 Stryker Corporation (USA)
  • 6.23.1 Stryker Corporation (USA) Corporation Information
  • 6.23.2 Stryker Corporation (USA) Artificial Implants Description and Business Overview
  • 6.23.3 Stryker Corporation (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.23.4 Stryker Corporation (USA) Product Portfolio
  • 6.23.5 Stryker Corporation (USA) Recent Developments/Updates
• 6.24 Terumo Corporation (Japan)
  • 6.24.1 Terumo Corporation (Japan) Corporation Information
  • 6.24.2 Terumo Corporation (Japan) Artificial Implants Description and Business Overview
  • 6.24.3 Terumo Corporation (Japan) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.24.4 Terumo Corporation (Japan) Product Portfolio
  • 6.24.5 Terumo Corporation (Japan) Recent Developments/Updates
• 6.25 TTK Healthcare(India)
  • 6.25.1 TTK Healthcare(India) Corporation Information
  • 6.25.2 TTK Healthcare(India) Artificial Implants Description and Business Overview
  • 6.25.3 TTK Healthcare(India) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.25.4 TTK Healthcare(India) Product Portfolio
  • 6.25.5 TTK Healthcare(India) Recent Developments/Updates
• 6.26 Wright Medical Group(Netherlands)
  • 6.26.1 Wright Medical Group(Netherlands) Corporation Information
  • 6.26.2 Wright Medical Group(Netherlands) Artificial Implants Description and Business Overview
  • 6.26.3 Wright Medical Group(Netherlands) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.26.4 Wright Medical Group(Netherlands) Product Portfolio
  • 6.26.5 Wright Medical Group(Netherlands) Recent Developments/Updates
• 6.27 Zimmer Biomet Holdings (USA)
  • 6.27.1 Zimmer Biomet Holdings (USA) Corporation Information
  • 6.27.2 Zimmer Biomet Holdings (USA) Artificial Implants Description and Business Overview
  • 6.27.3 Zimmer Biomet Holdings (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
  • 6.27.4 Zimmer Biomet Holdings (USA) Product Portfolio
  • 6.27.5 Zimmer Biomet Holdings (USA) Recent Developments/Updates

7 Artificial Implants Manufacturing Cost Analysis

• 7.1 Artificial Implants Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Artificial Implants
• 7.4 Artificial Implants Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Artificial Implants Distributors List
• 8.3 Artificial Implants Customers

9 Artificial Implants Market Dynamics

• 9.1 Artificial Implants Industry Trends
• 9.2 Artificial Implants Growth Drivers
• 9.3 Artificial Implants Market Challenges
• 9.4 Artificial Implants Market Restraints

10 Global Market Forecast

• 10.1 Artificial Implants Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Artificial Implants by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Artificial Implants by Type (2022-2027)
• 10.2 Artificial Implants Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Artificial Implants by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Artificial Implants by Application (2022-2027)
• 10.3 Artificial Implants Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Artificial Implants by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Artificial Implants by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List